Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous Fluoride Toothpaste for Dentine Hypersensitivity
NCT06733285Completed
- Sponsor
- Haleon
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, single-blind trial of stannous fluoride in dentin hypersensitivity (DH) (2 arms), sponsored by Haleon. Primary endpoints: Least Square (LS) Mean Change From Baseline in Schiff Sensitivity Score at 15 days, LS Mean Change From Baseline in Tactile Threshold at 15 days and 4 more. Started Feb 2025; status: completed.
02
Drugs
stannous fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06733285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06733285.